Conference Coverage
Conference Coverage
02/23/2024

Anthony Calabro, MA

Anthony Calabro, MA
Researchers assessed the efficacy of venetoclax-based treatments for patients with relapsed/refractory chronic lymphocytic leukemia. This study was presented at the 65th ASH Annual Meeting & Exposition...
02/23/2024
Conference Coverage
Conference Coverage
12/18/2023

Anthony Calabro, MA

Anthony Calabro, MA
In effort to understand the effect of the COVID-19 pandemic among patients with sickle cell disease, researchers compared outcomes and characteristics of hospitalized patients both before and during the...
12/18/2023
Conference Coverage
Conference Coverage
12/12/2023

Anthony Calabro, MA

Anthony Calabro, MA
In their case-controlled study that utilized the National Inpatient Sample 2016-2019 database, researchers set out to examine the relationship between leukemia and sickle cell trait.
12/12/2023
Immunology
virus immune cells
Immunology
12/31/2021
The researchers analyzed 569 patients with multiple myeloma, stratified patients on the basis of their percentage of CD56-expressing clonal MM cells, and then evaluated patient outcomes based on this...
12/31/2021
Tumors
cancer cells
Tumors
12/14/2021
To examine the prognostic value of flow cytometry plus PET/CT scanning for detecting minimal residual disease in patients with multiple myeloma, researchers conducted an observational cohort study of 94...
12/14/2021
Patient Outcomes
stem cells
Patient Outcomes
12/14/2021
For their study, the researchers aimed to clarify the mechanisms behind racial and ethnic disparities in multiple myeloma disease outcomes by investigating the demographic, clinical, and molecular features...
12/14/2021
Multiple Myeloma
blood cells circulating
Multiple Myeloma
12/09/2021
The MAIA study was a phase 3 trial comparing lenalidomide and dexamethasone alone with daratumumab as an add-on therapy to lenalidomide and dexamethasone in patients with transplant-ineligible newly...
12/09/2021
Amyloidosis
pill bottle
Amyloidosis
12/09/2021
The ANDROMEDA study was a phase 3 trial comparing bortezomib, cyclophosphamide, and dexamethasone therapy with daratumumab as an add-on therapy in patients with light chain amyloidosis.
12/09/2021
Treatment
Pills
Treatment
12/09/2021
The APOLLO study was a phase 3 trial comparing pomalidomide and dexamethasone therapy with daratumumab as an add-on therapy in patients with relapsed or refractory multiple myeloma who were refractory to...
12/09/2021
Treatment
colorful pills
Treatment
11/30/2021
The researchers conducted 2 studies to test the oral, small-molecule, next-generation sickle hemoglobin inhibitor would safely and substantially reduce erythrocyte hemolysis and increase hemoglobin.
11/30/2021